Cost of diagnostic and therapeutic management of colorectal cancer according to stage at diagnosis in the Calvados Département, France

European Journal of Health Economics

Volumn 4, Issue 2, 2003, Pages 102-106

  Bouvier, V ^a,c   Reaud, J M ^b   Gignoux, M ^a   Launoy, G ^a  

^a UNIVERSITÉ DE CAEN   (France)

^b Assur Malad Serv Medical de Caen   (France)

^c INSERM   (France)

Author keywords

Colorectal cancer; Screening; Treatment cost

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CANCER DIAGNOSIS; CANCER INVASION; CANCER REGISTRY; CANCER SCREENING; CANCER STAGING; COLORECTAL CANCER; ECONOMICS; FEMALE; FRANCE; HEALTH CARE COST; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PUBLIC HEALTH; SCREENING TEST; SUBMUCOSA; VISCERAL METASTASIS;

EID: 0038267566     PISSN: 16187598     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10198-002-0160-3     Document Type: Article

References (18)

1. Alignon A, Com-Ruelle L, Dourgon P, et al (2001) La consommation médicale en 1997 selon les caractéristiques individuelles. CD-ROM. CREDES, Série Résultats: Paris
2. Allemand H (1994) Décisions éthiques et aspects socio-économiques de la prévention. Hepatogastro 1:443-446
3. Atkin WS, Whynes DK (2000) Improving the cost-effectiveness of colorectal cancer. J Natl Cancer Inst 92:513-514
4. Belon-Leneutre M, Schraub S, Mercier M, et al (1988) Evaluation des dépenses de santé au cours des 6 premiers mois après le diagnostic de cancer à partir d'un registre de population. Rev Epidemiol Sante Publique 36:318-324
5. De Macro MF, Janssen-Heijnen MLG, van der Hijden LH, et al (2000) Comorbidity and colorectal cancer according to subsite and stage: a population-based study. Eur J Cancer 36:95-99
6. Gyrd-Hansen D, Sogaard J, Kronborg O (1997) Analysis of screening data: colorectal cancer. Int J Cancer 26:1172-1181
7. Hardcastle JD, Chamberlain JO, Robinson MH, et al (1996) Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 348:1472-1427
8. Ineveld BM van, van Oortmarssen GJ, de Koning HJ, et al (1993) How cost-effective is breast cancer screening in different EC countries. Eur J Cancer 29A:1663-1668
9. Jouve JL, Remontet L, Dancourt V, et al. (2001) Estimation of screening test (Hemoccult) sensitivity in colorectal cancer mass screening. Br J Cancer 84:1477-1481
10. Koopmanschap MA, van Roijen L, Bonneux L, et al (1994) Current and future costs of cancer. Eur J Cancer 30A:60-65
11. Kronborg O, Fenger C, Olsen J, et al (1996) Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 348:1467-1471
12. Launoy G, Duffy SW, Prevost TC, et al (1997) Colorectal cancer mass screening: estimation of faecal occult blood test sensitivity, taking account cancer mean sojourn time. Int J Cancer 73:220-224
13. Maurel J, Pottier D, Grosclaude P, et al (1998) Prise en charge thérapeutique du cancer colique en France. Gastroenterol Clin Biol 22:S90-S96
14. O'Brien BD, Brown MG, Kephart G (2001) Estimation of hospital costs for colorectal cancer care in Nova Scotia. Can J Gastroenterol 15:43-47
15. Schraub S, Arveux P, Mercier M, et al (1996) Recours aux soins chirurgicaux et cot des cancers: deux études utilisant les données d'un registre de population. Rev Epidemiol Sante Publique 44:S33-S39
16. Sobin LH, Wittekind (1997) TNM classification of malignant tumor, 5th edn. UICC
17. Taplin SH, Barlow W, Urban N, et al (1995) Stage, age, comorbidity, and direct costs of colon, prostate, and breast cancer care. J Natl Cancer Inst 87:417-425
18. Whynes DK, Walker AR, Chamberlain JO, et al (1993) Screening and the costs of treating colorectal cancer. Br J Cancer 68:965-968